Cyclizine

Emergency Medicine Journal

Volumn 20, Issue 3, 2003, Pages 302-

  Dodd, T ^a   Doyle, T ^a  

^a DORSET COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIZINE; METOCLOPRAMIDE; NALBUPHINE; ONDANSETRON; OPIATE;

ANGINA PECTORIS; CLINICAL PROTOCOL; DRUG ANTAGONISM; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG INFORMATION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PALPITATION; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LETTER; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TACHYCARDIA; VAGUS TONE; VOMITING;

EID: 0038179789     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.20.3.302     Document Type: Letter

References (4)

1. Bassett KE, Schunk JE, Crouch BI, et al. Cyclizing abuse by teenagers in Utah. Am J Emerg Med 1996;14:472-4.
2. Poldermans D, Boersma E, Bax JJ, et al. Bisoprolol reduces cardiac death and myocardial infarction in high risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001;22:1353-8.
3. Wallace A, Layung B, Iateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischaemia. McSPI Research Group. Anaesthesiology 1998;88:7-17.
4. BMA/British Pharmaceutical Society of Great Britain. British National Formulary 42. London: BMA/BPSGB, Sept 2001:201.